Returns
8.60%
Loading chart...
Fundamentals
Large Cap
Financial - Banking
Market Cap (Cr)
2561.64
Earning Per Share
17.5
Dividend Yield
0.45%
P/E Ratio
25.41
P/B Ratio
7.58
Debt to Equity
0.06
Performance
min-value
max-value
Open
56,601.30
52-wk High
75,250.00
High
56,601.30
52-wk Low
75,250.00
Low
56,601.30
Band
75,250.00
Lower Circuit
56,601.30
Upper Circuit
75,250.00
Volume
56,601.30
VWAP
75,250.00
52 Week Performance
min-value
max-value

5.34% down side
up side5.34%

About the company
Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company began to offer Clinical Diagnostics Services.